Literature DB >> 17205404

Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks.

Neşe Demirtürk1, Tuna Demirdal, Dilek Toprak, Mustafa Altindiş, Orhan Cem Aktepe.   

Abstract

BACKGROUND/AIMS: The aim was to determine the seroprevalence rates for hepatitis B virus and hepatitis C virus and the frequency of hepatitis B core antibody seropositivity alone in residents of a city in Turkey. The subjects visited the Family Medicine Outpatient Clinics of a university hospital in Afyon for routine health checks between January 2002 and January 2004.
METHODS: A single serum sample was collected from subjects examined. The sera were analyzed by ELISA for hepatitis B surface antigen, hepatitis B surface antibody, anti-HBcIgG and anti-hepatitis C virus. Samples that were HBsAg-positive were also screened for hepatitis B early antigen and antibody. Subjects who were positive for anti-HBcIgG alone were considered to have "isolated anti-HBcIgG positivity".
RESULTS: 1320 persons weere screened the rates of positivity for HBsAg, anti- HBs, isolated anti-HBcIgG, and anti-hepatitis C virus were 6.6%, 27.2%, 6.1% and 2.2%, respectively. Eight percent of the 87 HBsAg-positive individuals were HBeAg-positive. Comparison of marker detection rates according to sex and age (younger than 50 years vs 50 years or older) revealed a significantly higher prevalence of HBsAg positivity in males than in females (p=0.02), and a significantly higher prevalence of anti-hepatitis C virus and anti-HBcIgG positivity in the older than in the younger group (p=0.001 and p=0.001, respectively).
CONCLUSION: According to our results, the rates of hepatitis B virus and hepatitis C virus seropositivities in our region are similar to those reported in recent studies from other parts of Turkey. But these results cannot be extrapolated to all residents of the Afyon area because a random sampling method was not used for statistical analysis. However, they provide a good reference for future studies because of the large number of cases investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205404

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  7 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Frequency of HCV infection in renal cell carcinoma patients.

Authors:  Burçin Budakoğlu; Sercan Aksoy; Çağatay Arslan; Ümmügül Üyetürk; Nalan Akgül Babacan; Muhammet Fuat Özcan; Ramazan Yıldız; Başak Bala Öven; Nuriye Yıldırım Özdemir; Ömer Dizdar; Süleyman Büyükberber; M Bülent Akıncı; Ibrahim Türker; Berna Öksüzoğlu; Kadri Altundag; Nurullah Zengin
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

Review 3.  Hepatitis C treatment: current and future perspectives.

Authors:  Saira Munir; Sana Saleem; Muhammad Idrees; Aaliyah Tariq; Sadia Butt; Bisma Rauff; Abrar Hussain; Sadaf Badar; Mahrukh Naudhani; Zareen Fatima; Muhmmad Ali; Liaqat Ali; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Zunaira Awan
Journal:  Virol J       Date:  2010-11-01       Impact factor: 4.099

4.  Seroprevalence of Hepatitis B and C among Children in Endemic Areas of Turkey.

Authors:  Murat Kangin; Mine Turhanoglu; Serda Gulsun; Bahri Cakabay
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

5.  Physician awareness of hepatitis C virus among different departments.

Authors:  Tolga Düzenli; Hüseyin Köseoğlu
Journal:  Clin Exp Hepatol       Date:  2020-12-30

6.  Eight-year seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital.

Authors:  Mine Turhanoğlu; Arzu Onur; Fulya Bayındır Bilman; Zeynep Ayaydın; Gülseren Samancı Aktar
Journal:  Int J Med Sci       Date:  2013-09-12       Impact factor: 3.738

Review 7.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.